Search

everythinglearnresearchcommunity

for

Search:↓

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Children with trichotillomania often pull hair from their scalp and may have other mental health issues.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

The document concludes that local flaps are effective for reconstructive surgery in the head and neck, offering good skin match and function.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Trichotillomania can cause severe complications like hairballs in the stomach, needing surgery and psychiatric care.

The summit aimed to speed up finding treatments for alopecia areata.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Mother and son diagnosed with a rare genetic hair loss condition with no effective treatment.

Early diagnosis and multidisciplinary care, including orthopedic surgery, can prevent long-term disability in IFAP syndrome.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Non-immune factors play a significant role in alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Ruxolitinib treatment may cause eyelash growth.